Nurse Anesthetist - CR in Monticello, MN Accepting Medicare

6 Nurse Anesthetist - CR nurses found. Showing 1 - 6

Mr. Gary Morris Hanson, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 291 102nd St Ne, Monticello, MN 55362 Phone: 763-878-2388    Fax: 763-878-3222

Chad Welle, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1013 Hart Blvd, Monticello, MN 55362 Phone: 763-295-2945

Ralph Kiffmeyer, CRNA Nurse Anesthetist, Certified Registered Medicare: Not Enrolled in Medicare Practice Location: 1013 Hart Blvd, Monticello, MN 55362 Phone: 763-295-2495

Joseph Mccrone, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1013 Hart Blvd, Monticello, MN 55362 Phone: 763-271-2421

Randy Rokala, CRNA Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1013 Hart Blvd, Monticello, MN 55362 Phone: 763-271-2421

Maria A Smith, Nurse Anesthetist, Certified Registered Medicare: Accepting Medicare Assignments Practice Location: 1013 Hart Blvd, Monticello, MN 55362 Phone: 763-295-2945

News Archive

New technology provides clearer picture to clinicians treating gynecological cancer

New technology developed at Western University is providing an improved way for radiation oncologists to deliver treatment to women with gynecological cancers, including vaginal, cervical and uterine cancer.

Exalenz Bioscience initiates BreathID clinical study to detect primary liver cancer

Exalenz Bioscience, a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced the initiation of a clinical study designed to investigate its BreathID test to non-invasively detect primary liver cancer, also known as Hepatocellular Carcinoma (HCC).

New monoclonal antibodies may provide blueprint for effective Alzheimer's disease treatments

Scientists at NYU Langone Medical Center's Center for Cognitive Neurology have evidence that monoclonal antibodies they developed may provide the blueprint for effective treatments for Alzheimer's disease and other neurodegenerative diseases, such as Parkinson's disease.

Clinicians need to discuss disorders of consciousness with ethical sensitivity

New tools have confirmed high rates of misdiagnosis of patients with chronic disorders of consciousness, such as the vegetative state. An increasing number of patients' families wish to use these novel techniques for diagnosis, prognosis, and treatment.

Read more Medical News

› Verified 6 days ago